Vaxxinity Analysis
| VAXXDelisted Stock | USD 2.72 0.19 6.53% |
Vaxxinity is overvalued with Real Value of 2.17 and Hype Value of 2.72. The main objective of Vaxxinity pink sheet analysis is to determine its intrinsic value, which is an estimate of what Vaxxinity is worth, separate from its market price. There are two main types of Vaxxinity's stock analysis: fundamental analysis and technical analysis.
The Vaxxinity pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Vaxxinity |
Vaxxinity Pink Sheet Analysis Notes
About 51.0% of the company outstanding shares are owned by insiders. The book value of Vaxxinity was at this time reported as 0.11. The company has Price/Earnings To Growth (PEG) ratio of 0.05. Vaxxinity recorded a loss per share of 0.45. The entity had not issued any dividends in recent years. Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.The quote for Vaxxinity is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Mei JD at 254 244 5739 or visit https://www.vaxxinity.com.Vaxxinity Investment Alerts
| Vaxxinity is not yet fully synchronised with the market data | |
| Vaxxinity has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (56.93 M) with loss before overhead, payroll, taxes, and interest of (1.87 M). | |
| Vaxxinity currently holds about 128.23 M in cash with (57.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02. | |
| Roughly 51.0% of the company outstanding shares are owned by insiders |
Vaxxinity Upcoming and Recent Events
Earnings reports are used by Vaxxinity to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Vaxxinity Thematic Classifications
In addition to having Vaxxinity pink sheet in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Vaxxinity Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 14.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaxxinity's market, we take the total number of its shares issued and multiply it by Vaxxinity's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Vaxxinity Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vaxxinity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vaxxinity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vaxxinity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hornig George R over six months ago Acquisition by Hornig George R of 129187 shares of Vaxxinity subject to Rule 16b-3 | ||
Blatt Gregory R over six months ago Acquisition by Blatt Gregory R of 129187 shares of Vaxxinity at 2.09 subject to Rule 16b-3 | ||
United Biomedical Inc over a year ago Purchase by United Biomedical Inc of 100000 shares of Vaxxinity | ||
Prime Movers Lab Fund I Lp over a year ago Sale by Prime Movers Lab Fund I Lp of 1251 shares of Vaxxinity | ||
Smith James Alan over a year ago Acquisition by Smith James Alan of 132352 shares of Vaxxinity subject to Rule 16b-3 | ||
Reese Lou over a year ago Vaxxinity exotic insider transaction detected | ||
Smith James Alan over a year ago Vaxxinity exotic insider transaction detected | ||
Reese Lou over a year ago Acquisition by Reese Lou of 620000 shares of Vaxxinity subject to Rule 16b-3 | ||
Smith James Alan over a year ago Vaxxinity exotic insider transaction detected |
Vaxxinity Outstanding Bonds
Vaxxinity issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vaxxinity uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vaxxinity bonds can be classified according to their maturity, which is the date when Vaxxinity has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Vector Group 105 Corp BondUS92240MBJ62 | View |
Vaxxinity Predictive Daily Indicators
Vaxxinity intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vaxxinity pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Vaxxinity Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Vaxxinity prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vaxxinity shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Vaxxinity. By using and applying Vaxxinity Pink Sheet analysis, traders can create a robust methodology for identifying Vaxxinity entry and exit points for their positions.
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Vaxxinity to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |